Episode 7: Giovanni Amabile, PhD, CEO of Enthera, Developing first-in-class biologics for type 1 diabetes

<p>In this episode, Giovanni Amabile joins Monica Westley to discuss the future of Enthera. Enthera is a biotech company building a pipeline of first-in-class biologics for several autoimmune conditions, with a focus in type 1 diabetes and inflammatory bowel disease.  </p>